2nd World-China Immunotherapy & Gene Therapy Congress

IGC is dedicated to establishing the International production and research platform for immunotherapy and gene therapy sectors.Last year’s IGC was successfully held in Wuhan in 2017, attracting 738 participants, including industry, academia, clinic and so on, and inviting 51 distinguished scientists and scholars, leading scientists and researchers from home and abroad as honorable speakers.

In July 2018, we will hold the 2nd World-China Immunotherapy & Gene Therapy Congress, and invite more than 50 domestic and overseas well-known experts, scholars and R&D scientists from pioneering organizations and leading enterprises to specifically focus on academic and industrial hot issues and challenges. From three aspects of drug discovery, clinical development and industrialization, IGC 2018 will interpret domestic and foreign immunotherapy policies; share the latest clinical cases and data of immunotherapy from home and abroad; discuss the clinical application of various kinds of immunotherapy combination; release thelatest breakthrough in the cutting-edge study, technology and products in immune and gene therapy in the globe.